Start here if you're new
what it is
Metropolitan Bank is a New York lender that mixes regular banking with specialty services for municipalities, real estate closings, and foreign-investor accounts.
how it gets paid
Last year Metropolitan Bank made $515M in revenue. Commercial banking was the main engine at $250M, or 49% of sales.
why it's growing
Revenue grew 10.0% last year. The supplied earnings data is messy. EDGAR-backed figures show $378M in quarterly revenue and $3.89 EPS.
what just happened
The cleanest hard datapoint is revenue: latest-quarter sales reached $378M, up 186% vs. prior year.
At a glance
B balance sheet — gets the job done, barely
75/100 earnings predictability — reasonably predictable
13.8x trailing p/e — the market's not buying it — or you found a deal
1.0% dividend yield — cash in your pocket every quarter
$5.93 fy2024 eps est
xvary composite: 49/100 — below average
What they do
Metropolitan Bank is a New York lender that mixes regular banking with specialty services for municipalities, real estate closings, and foreign-investor accounts.
This bank wins by doing boring jobs other banks do not want. If your business runs a 1031 exchange, a title escrow, or a municipal account, changing banks means changing process, paperwork, and trust. Metropolitan focuses on middle-market clients with $5 million to $400 million in revenue, then adds specialty services on top, which helps a 291-employee bank punch above its weight.
How they make money
$515M
annual revenue · their business grew +10.0% last year
Commercial banking
$250M
Corporate cash management
$95M
Municipal and public entity banking
$70M
Real estate escrow and 1031 services
$55M
Retail banking and other fees
$45M
The products that matter
commercial lending
Commercial & Industrial Loans
core earnings engine
This is where the bank earns its spread. If loan yields stay ahead of deposit costs, earnings work. If that gap narrows, the math gets less friendly very fast.
spread income
business banking services
Treasury Management
fee income support
Fee income matters more at a small bank because it softens the blow when lending spreads tighten. The catch: this page does not break out the mix, so you should treat it as support, not the main act.
fee income
funding base
Commercial Deposits
sets cost of funds
Deposits are the raw material. If the bank has to pay up to keep them, loan growth alone does not save you. With price stability at 10/100, the stock has already shown how quickly the market reacts to funding anxiety.
cost of funds
Key numbers
$5.93
fy2024 eps
That is the latest full-year earnings power from. At a $79.50 stock price, you are paying 13.8 times that number.
$515M
annual revenue
This is the size of the business from EDGAR. Against a roughly $964M market cap, the bank trades at about 1.9 times sales.
$268M
long-term debt
Debt equals 22% of capital. Translation: leverage is manageable, but you cannot ignore funding risk in a bank.
1.65
beta
Beta measures stock volatility. Plain English: MCB tends to move more than the market. So what: you need a stronger stomach than the average bank investor.
Financial health
B
strength
- balance sheet grade B — adequate — nothing special
- risk rank 3 — safer than 50% of stocks
- price stability 10 / 100
- long-term debt $268M (22% of capital)
B — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for MCB right now.
source: institutional data · return history unavailable
What just happened
beat estimates
The cleanest hard datapoint is revenue: latest-quarter sales reached $378M, up 186% vs. prior year.
The supplied earnings data is messy. EDGAR-backed figures show $378M in quarterly revenue and $3.89 EPS, while shows Q4 2024 EPS at $1.88 and Yahoo lists the last reported EPS at $0.67. Translation: revenue clearly jumped, but you should treat the EPS line with caution until the next report.
$129M
quarterly revenue
$1.88
q4 2024 eps
186%
revenue vs. last year growth
the number that mattered
$378M matters most because it is the least disputed figure in the data set, and a 186% jump is too large to ignore.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
MCB already chose the hard part in public: it sold $179M of stock at $85 a share. Now you are judging whether that dilution buys better earnings power, cleaner funding, or just a larger denominator.
med
Capital deployment misses the mark
The raise equals roughly 19% of the current $964M market cap. That is big enough that weak returns will show up in per-share math fast.
If management cannot explain where the $179M goes and what return it earns, the discount to the $85 raise price has a reason to stick.
med
Funding pressure eats the spread
Banks borrow short and lend long. In human-speak: if deposit pricing rises faster than loan yields, the margin gets squeezed even when loan balances look fine.
That would pressure profitability and make the recent EPS beat look more temporary than durable.
med
Credit mistakes matter more at this size
This is a $515M revenue New York bank, not a national lender with a dozen engines. A few bad loans carry more weight here than they would at a giant bank.
If credit costs rise, the market will not wait around patiently at 10/100 price stability.
The key insight: the stock does not need perfection. It does need evidence. Better earnings with weak deployment is not enough. Better earnings because the new capital earns well is the whole case.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
Q1 2026 earnings report
Estimated for April 20, 2026. Consensus in this snapshot is $84.44M in revenue and $2.18 in EPS. You want to hear how management connects that print to the fresh capital.
capital
Use of the $179M raise
Specifics matter. More loans, stronger capital ratios, better funding flexibility, or something else. If management stays vague, the market has no reason to get generous.
price action
The gap to the $85 offering price
MCB still trades at $79.50, or 6.5% below the recent raise price. Closing that gap would signal that investors are starting to buy the deployment story.
risk
Funding commentary on deposits and margin
Listen for any shift from profitable growth to defensive deposit pricing. That is often where a bank quarter goes from fine on paper to weaker underneath.
Analyst rankings
earnings predictability
75 / 100
in human-speak, the earnings line looks more readable than the stock quote.
risk rank
3
That puts MCB around the middle of the pack. Safer than some small caps, but nobody mistakes this for a bunker stock.
price stability
10 / 100
Translation: the business may be steadier than the chart. Your timing still matters because the market does not price uncertainty gently here.
source: institutional data
Institutional activity
institutional ownership data for MCB is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$80
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive